Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes

Immunobiology

Volumn 197, Issue 5, 1997, Pages 522-533

  Cordero, Oscar J ^a   Salgado, Francisco J ^a   Viñuela, Juan E ^b   Nogueira, Montserrat ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; FLUORESCENCE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOBLAST; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030671453     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80084-8     Document Type: Article

References (37)

1. FLEISCHER, B. 1994. CD26: a surface protease involved in T-cell activation. Immunol. Today 15:180.
2. DANG, N. H., Y. TORIMOTO, S. F. SCHLOSSMAN, and C. MORIMOTO. 1990. Human CD4 helper T cell activation; functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J. Exp. Med. 172: 649.
3. BAUVOIS, B. 1988. A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV. Biochem. J. 252: 723.
4. + T-cells that exhibit a trans-endothelial migratory capacity. J. Immunol. 154: 3062.
5. SCHEEL-TOELLNER, D., E. RICHTER, K.-M. TOELLNER, N. REILING, H.-N. WACKER, H.-D. FLAD, and J. GERDES. 1995. CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-γ. Lab. Invest. 73: 685.
6. MASUAMA, J.-I., J. S. BERMA, W. W. CRUIKSHANK, C. MORIMOTO, and D. M. CENTER. 1992. Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J. Immunol. 148: 1367.
7. SCHÖN, E., S. JAHN, S. T. KIESSIG, H.-U. DEMUTH, K. NEUBERT, A. BARTH, R. V. BAEHR, and S. ANSORGE. 1987. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur. J. Immunol. 17: 1821.
8. KAMEOKA, J., T. TANAKA, Y. NOJIMA, S. F. SCHLOSSMAN, and C. MORIMOTO. 1993. Direct association of adenosine deaminase with T cell activation antigen, CD26. Science 261: 466.
9. DE MEESTER, I., G. VANHAM, L. KESTENS, G. VANHOOF, E. BOSMANS, P. GIGASE, and S. SCHARPÉ. 1994. Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24: 566.
10. + cells. Science 262: 2045.
11. BLAZQUZE, M. V., J. A. MADUEÑO, R. GONZALEZ, R. JURADO, W. W. BACHOVCHIN, J. PENA, and E. MUÑOZ. 1992. Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J. Immunol. 149: 3073.
12. GUTHEIL, W. G., M. SUBRAMANYAM, G. R. FLENTKE, D. G. SANFORD, E. MUÑOZ, B. T. HUBER, and W. W. BACHOVCHIN. 1994. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): A possible mechanism for Tat's immunosuppressive activity. Proc. Natl. Acad. Sci. USA 91: 6594.
13. TRINCHIERI, G. 1994. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in th generation of T-helper cells type I and cytotoxic lymphocytes. Blood 84: 4008.
14. MUÑOZ, E., M. V. BLAZQUEZ, J. A. MADUEÑO, G. RUBIO, and J. PEÑA. 1992. CD26 induces T-cell proliferation by tyrosine protein phosphorylation. Immunology 77: 43.
15. BAUVOIS, B., J. SANĆEAU, and J. WIETZERBIN. 1992. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-α. Eur. J. Immunol. 22: 923.
16. CORDERO, O. J., C. SARANDESES, and M. NOGUEIRA. 1994. Prothymosin a receptors on peripheral blood mononuclear cells. FEBS Lett. 341: 23.
17. 1, a novel 105 kD T cell activation antigen defined by a monoclonal antibody. J. Immunol. 133: 1250.
18. KOBAYASHI, M., L. FITZ, M. RYAN, R. M. HEWICK, S. C. CLARK, S. CHAN, R. LOUDON, F. SHERMAN, B. PERUSSIA, and G. TRINCHIERI. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827.
19. NEUBERT, R., H. HELGE, and D. NEUBERT. 1995. Thalidomide and the immune system. Down-regulation of the CD26 receptor, probably involved in the binding of HIV components to T cells in primates. Life Sci. 56: 407.
20. MORIMOTO, C., Y. TORIMOTO, G. LEINSON, C. E. RUDD, M. SCHRIEBER, N. H. DANG, N. L. LETVIN, and S. F. SCHLOSSMAN. 1989. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J. Immunol. 143: 3430.
21. TORIMOTO, Y., N. H. DANG, E. VIVIER, T. TANAKA, S. F. SCHLOSSMAN, and C. MORIMOTO. 1991. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J. Immunol. 147: 2514.
22. FLEISCHER, B. 1987. A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J. Immunol. 138: 1346.
23. CHAN, S. H., B. PERUSSIA, J. W. GUPTA, M. KOBAYASHI, M. POSPISIL, H. A. YOUNG, S. F. WOLF, D. YOUNG, S. C. CLARK, and G. TRINCHIERI. 1991. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869.
24. AMLOT, P. L., F. TAHAMI, D. CHINN, and E. RAWLINGS. 1996. Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. Clin. Exp. Immunol. 105: 176.
25. DESAI, B. B., P. M. QUINN, A. G. WOLITZKY, P. K. A. MONGINI, R. CHIZZONITE, and M. K. GATELY. 1992. IL-12 receptor. II. Distribution and regulation of receptor expression. J. Immunol. 148: 3125.
26. REINHOLD, D., U. BANK, F. BÜHLING, T. KÄHNE, D. KUNT, J. FAUST, K. NEUBERT, and S. ANSORGE. 1994. Inhibitors of dipeptidyl peptidase IV (DPIV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiol. 192: 121.
27. BÜHLING, F., D. KUNZ, D. REINHOLD, A. J. ULMER, M. ERNST, H.-D. FLAD, and S. ANSORGE. 1994. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat. Immunol. 13: 270.
28. FUJIWARA, H., M. FUKOAKA, K. YASUDA, M. UEDA, K. IMAI, Y. GOTO, H. SUGAMI, H. KANZAKI, M. MAEDA, and T. MORI. 1994. Cytokines stimulate dipeptidyl peptidase-IV expression on human luteinizing granulosa cells. J. Clin. Endocrinol. Metab. 79: 1007.
29. DUKE-COHAN, J. S., C. MORIMOTO, J. A. ROCKER, and S. F. SCHLOSSMAN. 1995. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptylpeptidase IV (CD26). J. Biol. Chem. 270: 14107.
30. DUKE-COHAN, J. S., C. MORIMOTO, J. A. ROCKER, and S. F. SCHLOSSMAN. 1996. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J. Immunol. 156: 1714.
31. SCHEEL, D., E. RICHTER, K.-M. TOELLNER, N. REILING, G. KEY, H.-H. WACKER, A. J. ULMER, H. D. FLAD, and J. GERDES. 1995. Leucocyte Typing V. White cell differentiating Antigens, SCHLOSSMAN, S. F. et al. (eds.), Oxford University Press. 1111 pp.
32. SIELING, P. A., X. H. WANG, M. K. GATELY, J. L. OLIVEROS, T. MCHUGH, P. F. BARNES, S. WOLF, L. GOLKAR, M. YAMAMURA, Y. YOGI, K. UKEMURA, T. H. REA, and R. L. MODLIN. 1994. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J. Immunol. 153: 3639.
33. SIELING, P. A. and R. L. MODLIN. 1994. Cytokine patterns at the site of mycobacterial infection. Immunobiol. 191: 378.
34. WANG, Z.-E., S. ZHENG, D. B. CORRY, D. K. DALTO, R. A. SEDER, S. L. REINER, and R. M. LOCKSLEY. 1994. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA 91: 12932.
35. TRINCHIERI, G. 1995. Interleukin-12 and interferon-γ. Am. J. Pathol. 147: 1534.
36. NASTALA, C. I., H. D. EDINGTON, T. G. MCKINNEY, H. TAHARA, M. A. NALESNIK, M. J. BRUNDA, M. K. GATELY, S. F. WOLF, R. D. SCHREIBER, W. J. STORKUS, and M. LOTZE. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153: 1697.
37. RIEMANN, D., A. KEHLEN, and J. LANGNER. 1995. Stimulation of the expression and the enzyme activity of aminopeptidase APN/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin. Exp. Immunol. 100: 277.